Clinical trial Recruiting at 1 site Interventional Ages 6 Months to 18

Using a new pathway to manage unexplained pain in children with severe neurological impairments

Official title: Implementation of the Pain and Irritability of Unknown Origin (PIUO) Pathway in Community Pediatric Practices

Run by University of British Columbia · NCT06869928 · Data updated 2026-11-12

This study is testing a new way for doctors to help manage unexplained pain in children with severe neurological impairments who can't tell us how they feel.

More Neuropathic Pain trials

Quick facts

Study typeInterventional
Ages6 Months to 18 Years
SexAll
Enrollment20 (estimated)
SponsorUniversity of British Columbia
Academic / other
Locations1 site (Vancouver, British Columbia)
StatusRecruiting
StartedJune 28, 2024
Main results expectedMarch 2026
Study endsMay 2026
Registry record updatedMarch 11, 2025
Trial IDNCT06869928 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include children aged 6 months to 18 years with severe neurological impairments who experience unexplained pain and irritability and cannot communicate their pain.

Probably not a fit

Patients who can localize their pain or have a known and treatable cause of pain will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study implements the Pain and Irritability of Unknown Origin (PIUO) Pathway in community pediatric practices to evaluate and manage unexplained pain and irritability in children with severe neurological impairments who cannot communicate their pain. The pathway, previously used in specialized hospital settings, aims to train community pediatricians in British Columbia to effectively utilize this tool. By enhancing the clinical care for these vulnerable children, the study seeks to create a systematic approach to pain management that can be sustained in community settings. The research will assess the feasibility and effectiveness of this implementation.

Why it matters

Potential benefit: If successful, this approach could significantly improve pain management and quality of life for children with severe neurological impairments.

How similar studies have gone: While the PIUO Pathway has been effective in specialized settings, this implementation in community practices is a novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Pain Pathway Intervention Inclusion Criteria:

* Children aged 6 months to 18 years with SNI (from any cause) with unexplained pain and irritability and whose cognitive or communication impairments prevent determination of pain location, cause, and type will be eligible to participate.
* Eligible children will have cognitive impairment or be non-verbal. Parents should have sufficient English skills, or have access to assistance, to participate in the clinic visits and complete survey tools.

Pain Pathway Intervention Exclusion Criteria:

* Children not within the specified age range
* Children with communication capabilities and cognitive development to localize their pain
* Children that have an explained and treatable cause of pain and irritability. Parents that do not have sufficient English skills, or have access to assistance, to participate in the clinic visits and complete survey tools.

Implementation Participant Inclusion Criteria:

* General pediatricians
* Practicing in a community clinic in British Columbia

Implementation Participant Exclusion Criteria:

\- Healthcare professionals who are not general pediatricians (e.g., pediatrician specialists, nurse practitioners, nurses, other allied health professionals)

Where it's running

  • BC Children's Hospital
    Vancouver, British Columbia, Canada
    Recruiting

Study contacts

  • Principal investigator: Hal Siden, MD — University of British Columbia and BC Children's Hospital Research Institute
  • Study coordinator: Sharon Hou, PhD
  • Email: sharon.hou@bcchr.ca
  • Phone: 604-875-2345

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.